{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:54:39Z","timestamp":1787853279008,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.fertnstert.2009.03.068","type":"journal-article","created":{"date-parts":[[2009,9,19]],"date-time":"2009-09-19T04:58:21Z","timestamp":1253336301000},"page":"558-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Effects of taxane-based chemotherapy on inhibin B and gonadotropins as biomarkers of spermatogenesis"],"prefix":"10.1016","volume":"94","author":[{"given":"Eleftherios","family":"Chatzidarellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nektaria","family":"Makrilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Giza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Georgiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Alamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos N.","family":"Syrigos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2009.03.068_bib1","series-title":"Cancer: principles and practice of oncology","first-page":"390","article-title":"Pharmacology of cancer chemotherapy: antimicrotubule agents","author":"Rowinsky","year":"2005"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib2","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1200\/JCO.1999.17.10.3333","article-title":"American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants","volume":"17","author":"Hensley","year":"1999","journal-title":"J\u00a0\u00a0Clin Oncol"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib3","unstructured":"National Cancer Institute Cancer Therapy Evaluation Program. Common terminology criteria for adverse events version 3.0. Available from: URL:http:\/\/ctep.info.nih.gov."},{"key":"10.1016\/j.fertnstert.2009.03.068_bib4","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","article-title":"American Society of Clinical Oncology recommendations on fertility preservation in cancer patients","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib5","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1200\/JCO.2002.07.175","article-title":"Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors","volume":"20","author":"Schover","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/(SICI)1097-0142(19990815)86:4<697::AID-CNCR20>3.0.CO;2-J","article-title":"Having children after cancer: a pilot survey of survivors' attitudes and experiences","volume":"86","author":"Schover","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/pon.784","article-title":"Fertility issues for young adult survivors of childhood cancer","volume":"13","author":"Zebrack","year":"2004","journal-title":"Psychooncology"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib8","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1200\/JCO.2005.01.134","article-title":"Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy","volume":"23","author":"Duffy","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.eururo.2007.03.085","article-title":"Semen quality in men with malignant diseases before and after therapy and the role of cryopreservation","volume":"52","author":"Trottmann","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib10","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s00120-005-0840-6","article-title":"[Cryopreserved human sperm deposits: usability after decades of storage.]","volume":"44","author":"Bolten","year":"2005","journal-title":"Urologe A"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ctrv.2003.07.005","article-title":"Male fertility preservation and cancer treatment","volume":"30","author":"Puscheck","year":"2004","journal-title":"Cancer Treat Rev"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2009.03.068_bib12","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ejogrb.2003.11.002","article-title":"Testicular function following chemo-radiotherapy","volume":"113","author":"Colpi","year":"2004","journal-title":"Eur J Obstet & Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib13","first-page":"241","article-title":"Significant endocrinological parameters for the assessment of male reproductive toxicity induced by 1,3-dinitrobenzene or Taxol","volume":"26","author":"Takizawa","year":"2001","journal-title":"J Toxicol Sci"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/JCO.1997.15.1.239","article-title":"Fertility after chemotherapy for testicular germ cell cancers","volume":"15","author":"Lampe","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib15","unstructured":"US Food and Drug Administration. CDER human drugs. Available from: URL:http:\/\/www.fda.gov\/cder\/index.html."},{"key":"10.1016\/j.fertnstert.2009.03.068_bib16","series-title":"Cancer: principles and practice of oncology","first-page":"2560","article-title":"Adverse effects of treatment: gonadal dysfunction","author":"Meistrich","year":"2005"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib17","series-title":"Campbell's urology","first-page":"3745","article-title":"Male reproductive physiology","author":"Schlegel","year":"2002"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib18","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0022-3476(82)80034-6","article-title":"Testicular volumes of adolescents","volume":"101","author":"Daniel","year":"1982","journal-title":"J Pediatr"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2009.03.068_bib19","first-page":"1","article-title":"The frequency of mumps and of mumps orchitis and the consequences for sexuality and fertility","volume":"2","author":"Lambert","year":"1951","journal-title":"Acta Genet Stat Med"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0022-5347(01)66349-3","article-title":"Measurement of testicular volume: comparison of 3 different methods","volume":"155","author":"Taskinen","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib21","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0959-8049(98)00396-7","article-title":"Low serum inhibin B concentrations in male survivors of childhood malignancy","volume":"35","author":"Lahteenmaki","year":"1999","journal-title":"Eur J Cancer"},{"issue":"Pt 4","key":"10.1016\/j.fertnstert.2009.03.068_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/000456320003700401","article-title":"Does measurement of inhibin have a clinical role?","volume":"37","author":"Groome","year":"2000","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/beem.2000.0086","article-title":"Inhibin B in the assessment of seminiferous tubular function","volume":"14","author":"Andersson","year":"2000","journal-title":"Baillieres Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib24","first-page":"3341","article-title":"Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction","volume":"81","author":"Anawalt","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib25","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1093\/humrep\/12.11.2376","article-title":"Inhibin B in men with normal and disturbed spermatogenesis","volume":"12","author":"Klingmuller","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib26","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1210\/jc.2003-032148","article-title":"Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men: significance of adequate reference values from proven fertile men","volume":"89","author":"Andersson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib27","first-page":"2496","article-title":"Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples","volume":"84","author":"Von Eckardstein","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib28","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1210\/jcem.83.9.5121","article-title":"Serum inhibin B as a marker of spermatogenesis","volume":"83","author":"Pierik","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.068_bib29","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.fertnstert.2007.09.048","article-title":"Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers","volume":"90","author":"Reh","year":"2008","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209006384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209006384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:41:41Z","timestamp":1758008501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028209006384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0015028209006384"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.03.068","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of taxane-based chemotherapy on inhibin B and gonadotropins as biomarkers of spermatogenesis","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.03.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}